Bullish Case: FDA approvals and insurer coverage suggest a future uptake in Bluebird's therapies, potentially reviving the stock.


Bearish Case: Long-term performance decline, safety concerns, and stiff competition challenge Bluebird's market position.


Potential Outcomes:

1. Increased adoption (30% chance): Driven by insurer coverage and therapeutic efficacy.

2. Market share loss (40% chance): Due to competition and safety issues.

3. Acquisition (20% chance): Given gene therapy interest.

4. Financial struggle (10% chance): If costs outweigh revenue.


Trading Oracle: Sign Up to access trading oracle trade ideas.


February 07, 2024


Bluebird bio Forecast

[BLUE]  Bluebird bio
Price Forecast: BEARISH    Price Action: MEAN REVERTING (?)



Make More Profitable Trades with BLUE Forecasts + Trading Strategies







BLUE Balanced News:
















Correlated Stock Forecasts

Assets that tend to move strongly with BLUE



QURE Forecast + Options Trading Strategies   [QURE]  uniQure (0.75)


BTAI Forecast + Options Trading Strategies   [BTAI]  BioXcel Therapeutics (0.73)


BILI Forecast + Options Trading Strategies   [BILI]  Bilibili (0.71)


CNYA Forecast + Options Trading Strategies   [CNYA]  BlackRock Institutional Trust Company N.A. - iShares MSCI China (0.71)


EWH Forecast + Options Trading Strategies   [EWH]  BlackRock Institutional Trust Company N.A. - iShares MSCI Hong Kong (0.7)



Uncorrelated Stock Forecasts

Assets with little price relationship to BLUE



XLRE Forecast + Options Trading Strategies   [XLRE]  Real Estate Select Sector SPDR (-0.0)


LGF.A Forecast + Options Trading Strategies   [LGF.A]  Lions Gate Entertainment (0.0)


SLDB Forecast + Options Trading Strategies   [SLDB]  Solid Biosciences (0.0)


UWM Forecast + Options Trading Strategies   [UWM]  ProShares Ultra Russell2000 (-0.0)


SABR Forecast + Options Trading Strategies   [SABR]  Sabre (-0.0)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against BLUE



AKAM Forecast + Options Trading Strategies   [AKAM]  Akamai (-0.68)


IONS Forecast + Options Trading Strategies   [IONS]  Ionis Pharmaceuticals (-0.68)


VRTX Forecast + Options Trading Strategies   [VRTX]  Vertex Pharmaceuticals (-0.7)


PBR Forecast + Options Trading Strategies   [PBR]  Petroleo Brasileiro S.A. Petrobras (-0.71)


MCK Forecast + Options Trading Strategies   [MCK]  Mckesson (-0.71)


BLUE News over Time





Click points to explore news by date. News sentiment ranges from -10 (very negative) to +10 (very positive) where 0 is neutral.

Most Recent BLUE News






Become a more profitable investor with AI optimized trading strategies






×

Chat with Helium


 Ask me any question!